# CVS Caremark 去年將 Zepbound 從其涵蓋藥物清單中移除。

*biotech · news · 2026-05-28 · NBC News*

## Key points

- CVS Caremark 將於 2024 年 10 月 1 日前將 Zepbound 重新加入其藥物目錄。
- Lilly 新的減重藥丸 Foundayo 也將從週一起被 CVS Caremark 涵蓋。
- 約有 2,500 萬至 3,000 萬使用 CVS Caremark 標準藥物目錄的人將受此變動影響。
- 儘管列入藥物目錄，Zepbound 的最終保險涵蓋仍取決於各個雇主的決定。

CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered medications last year, drugmaker Eli Lilly said Thursday. CVS Caremark is one of the country’s largest pharmacy benefit managers, deciding which medications millions of people in the U.S. can get through insurance and how much they pay out of pocket. The decision to remove Zepbound from CVS Caremark’s list of covered drugs, or formulary, last year sparked backlash from patients, who said they were forced to switch to rival drug Wegovy, from Novo Nordisk, despite having gotten better results on Zepbound. The move did not affect patients taking Lilly’s diabetes drug Mounjaro, which contains the same active ingredient as Zepbound. A class-action lawsuit challenging the decision was filed in September and remains active. Zepbound has a monthly list price of $1,086, although Lilly offers discounts for patients paying in cash. Even then, people can end up paying hundreds of dollars a month for the medication. Lilly said Thursday that Zepbound will return to CVS Caremark’s formulary by Oct. 1 and that some patients with private insurance could pay as little as a $25 copay. Foundayo, Lilly’s weight loss pill that was approved in April, will also be added to the list starting Monday. A CVS Caremark spokesperson said the change applies to its standard formulary, affecting about 25 million to 30 million people. Being added to the formulary does not guarantee the drugs will be covered by every insurance plan, since employers often make the final decision about whether to pay for the medications. But being on the list can make coverage more widely available. The country’s two other major PBMs — Express Scripts and Optum Rx — already cover Zepbound.

**Companies:** CVS Caremark, Eli Lilly
**Countries:** United States

[Read the full story on NBC News](https://www.nbcnews.com/health/health-news/cvs-caremark-will-cover-lillys-weight-loss-drug-zepbound-rcna347253)

---

Canonical: https://newsio.io/zh-TW/n/55d53b03-c8d7-4aa1-8546-2ba88a5fac08/cvs-caremark-zepbound-lilly-mounjaro
Summarized by Newsio from NBC News. https://newsio.io/how-it-works